Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 10;20(1):1221.
doi: 10.1186/s12889-020-09321-0.

Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India

Affiliations

Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India

Basant Kumar Panda et al. BMC Public Health. .

Abstract

Background: Between 2010 and 2018, measles-related mortality had halved in India mainly with effective measles vaccination campaigns and widespread coverage across the states and population subgroups. Despite the commendable vaccination coverage, 2.9 million children in India missed the first dose of measles vaccine (MCV1) in 2017, and many of those vaccinated were not vaccinated at the recommended age (i.e. between 9 and 12 months). This study analyzed pattern and correlates of MCV1 coverage and MCV1 administration at recommended age among children aged 12-23 months in India.

Methods: We used the official data from the recent round of National Family Health Survey (NFHS-4), a nationally representative cross-sectional household survey in India conducted in 2015-16. Descriptive statistics and logistic regression analysis were applied to ascertain the influence of specified socio-demographic variables affecting measles vaccination coverage in India.

Results: The study revealed the distinct variations in coverage of MCV1 between the districts of India. There were also major challenges with age recommended vaccination, with about 15% of eligible children not vaccinated within the recommended age range, attributable to several socio-demographic factors. Significantly, antenatal care utilization of mothers strongly influenced MCV1 coverage and age recommended MCV1 coverage in India. The study also identified that children who missed MCV1 had one or more adverse health risks such as malnutrition, anemia and diarrhea disease.

Conclusions: A socio-economic gradient exists in India's MCV1 coverage, mediated by antenatal visits, education of mothers, and highlighted socio-demographic factors. Infection with measles was significantly correlated with greater anthropometric deficits among the study cohort, indicating a wider range of benefits from preventing measles infection. Eliminating morbidity and mortality from measles in India is feasible, although it will require efficient expanded program on immunization management, enhanced health literacy among mothers, continuing commitment from central state and district political authorities.

Keywords: India; MCV1; Measles; National Family Health Survey 4.

PubMed Disclaimer

Conflict of interest statement

Authors declared that they do not have any competing interest.

Figures

Fig. 1
Fig. 1
Schematic presentation of first dose of measles vaccination (MCV1) in India, 2015–16
Fig. 2
Fig. 2
State variation in measles vaccination (MCV1) coverage in India 2015–16
Fig. 3
Fig. 3
Level of measles vaccination (MCV1) coverage in the districts of India, 2015–16. Source: Author’s prepared map using NFHS-4 data (2015–16)
Fig. 4
Fig. 4
State variation in MCV1 coverage at recommended age in India, 2015–16
Fig. 5
Fig. 5
Timing of measles vaccination (MCV1) in India, 2015–16

Similar articles

Cited by

References

    1. van den Ent MM, Brown DW, Hoekstra EJ, Christie A, Cochi SL. Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008. J Infect Dis. 2011;204(Suppl 1):S18–S23. - PubMed
    1. Bogler L, Jantos N, Barnighausen T, Vollmer S. Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries. Vaccine. 2019;37(35):5073–5088. - PubMed
    1. Portnoy A, Jit M, Ferrari M, Hanson M, Brenzel L, Verguet S. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(4):e472–e481. - PMC - PubMed
    1. Organization WH . Organization WH: measles: factsheet. 2018. 2019.
    1. Dabbagh A, Laws RL, Steulet C, Dumolard L, Mulders MN, Kretsinger K, et al. Progress toward regional measles elimination — worldwide, 2000–2017. Morb Mortal Wkly Rep. 2018;67(47):1323–1329. - PMC - PubMed

Substances